This session was presented by the NMDP at the 2011 BMT Tandem Meeting on February 19, 2011, and is provided with permission from the CIBMTR® (Center for International Blood & Marrow Transplant Research®), the ASBMTTM (American Society for Blood and Marrow Transplantation) and the session faculty.
Program Description
Umbilical cord blood is being increasingly used as a source of hematopoietic stem cells in allogeneic transplantation in both adults and children. The NMDP Session at the 2011 BMT Tandem Meetings addressed these current topics in cord blood transplantation:
- Implications of the FDA licensure requirements becoming effective in October 2011
- Factors in cord blood unit selection, including HLA match, cell dose, and single or double cord transplants
- Match rates for adult and pediatric patients searching for cord blood units through the NMDP
Presentations
Implications of Cord Blood Licensure for Transplant Programs
Michael Boo, J.D.
National Marrow Donor Program
Minneapolis, Minnesota
Best Practices and Emerging Trends in Cord Blood Unit Selection
Karen Ballen, M.D.
Massachusetts General Hospital
Boston, Massachusetts
Applying Cord Blood Match Rates to Search Algorithms
Martin Maiers
National Marrow Donor Program
Minneapolis, Minnesota
Questions
If you have any questions regarding this presentation, call Renee Ryan at (800) 526-7809 ext. 8430 or e-mail rryan@nmdp.org.
This session is the intellectual property of the 2011 BMT Tandem Meetings. The content has been reviewed for compliance with rules and guidelines regarding speaker conflicts of interest, off-label use of pharmaceuticals and medical devices and other ACCME requirements. Any further use of this session is strictly prohibited unless prior permission has been granted.